Trial Profile
A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of etanercept in Chinese subjects with active rheumatoid arthritis receiving methotrexate
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Wyeth
- 12 Dec 2007 Status changed from recruitinig to completed.
- 03 May 2007 New trial record.